Health

Impulse Dynamics Secures $158M to Accelerate Heart Failure Pipeline

Financing follows major CMS coverage decision for CCM therapy and supports next-generation heart failure devices.

Enterprise Therapeutics Advances a Promising New Approach for Cystic Fibrosis

Positive Phase 1 data highlight strong safety, lung retention and momentum toward a new inhaled therapy for people with cystic fibrosis.

Lundbeck Reports Seizure Reductions in Rare Childhood-Onset Epilepsies

AES 2025 data highlight continued seizure improvement in patients treated with bexicaserin through long-term follow-up.

Genetic Study Offers New Hope for Millions With ME and Long COVID

Largest genetic investigation of ME to date points to clear biological drivers and future clinical trial paths.

Scottish Brain Sciences Opens New Alzheimer’s Clinical Research Centre at ONE BioHub

Aberdeen expansion widens access to early-stage trials and strengthens Scotland’s position in global brain health innovation.

Digital Cognitive Therapy Delivers Striking Cognitive Gains for UK Care Home Residents

A digital therapeutic designed to combat cognitive decline in people with dementia has produced remarkable improvements in cognitive and emotional outcomes in a recent UK pilot.